| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/17/2007 | US7205276 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205274 Hybrid peptides modulate the immune response |
| 04/17/2007 | US7205002 For causing a cell to die, for reducing intracellular glutathione, and sensitizing a cell to cytotoxic agents that the cell is resistant to due to the presence of intracellular glutathione |
| 04/17/2007 | US7204997 Responsive microgel and methods related thereto |
| 04/17/2007 | US7204980 Methods for inhibiting viral replication in vivo |
| 04/17/2007 | CA2387915C Direct compression polymer tablet core |
| 04/17/2007 | CA2323734C Quick disintegrating tablet in buccal cavity and production process thereof |
| 04/17/2007 | CA2321267C Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 04/17/2007 | CA2308721C Radio-opaque polymer biomaterials |
| 04/17/2007 | CA2283648C Polymeric carrier |
| 04/17/2007 | CA2270473C Compositions for disinfection of skin and mucous membrane |
| 04/17/2007 | CA2244494C Tabletting of erythritol |
| 04/17/2007 | CA2182417C Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 04/17/2007 | CA2141212C Defective adenovirus and corresponding complementation lines |
| 04/17/2007 | CA2133205C Stable polypeptide composition |
| 04/17/2007 | CA1341525C Biologically active bactericidal/permeability-increasing protein fragments |
| 04/12/2007 | WO2007041664A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 04/12/2007 | WO2007041364A2 Conjugates for modulating the immune tolerance |
| 04/12/2007 | WO2007041206A2 Drug delivery nanocarriers targeted by landscape phage |
| 04/12/2007 | WO2007041119A1 Transdermal drug delivery systems, devices, and methods employing hydrogels |
| 04/12/2007 | WO2007039974A1 Emulsion lotion |
| 04/12/2007 | WO2007039936A1 Compositions for application to mucosa |
| 04/12/2007 | WO2007039935A1 Solid external pharmaceutical composition |
| 04/12/2007 | WO2007039917A1 A vaccine |
| 04/12/2007 | WO2007039896A2 Security device and building block functions |
| 04/12/2007 | WO2007039769A1 Pharmaceutical compositions stabilized in glassy particles |
| 04/12/2007 | WO2007039645A1 African trypanosomiasis therapy with a nanobody-conjugated human trypanolytic factor |
| 04/12/2007 | WO2007039533A2 Antifungal composition |
| 04/12/2007 | WO2007039448A2 Use of conjugates of doxorubicin with lactosaminated albumin |
| 04/12/2007 | WO2007039437A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 04/12/2007 | WO2007039436A1 Treatment of neurodegenerative disorders |
| 04/12/2007 | WO2007039201A2 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/12/2007 | WO2007038867A1 Controlled-release oral dosage form |
| 04/12/2007 | WO2007038837A1 Silk proteins |
| 04/12/2007 | WO2007017452A3 N-vinylcaprolactam-based copolymers and the use thereof as solubilizers |
| 04/12/2007 | WO2007016560A3 Methods for preparing carbonate esters of poly(etylene glycol) |
| 04/12/2007 | WO2007016560A2 Methods for preparing carbonate esters of poly(etylene glycol) |
| 04/12/2007 | WO2007016306A3 HMGCoA REDUCTASE INHIBITOR CODRUGS AND USES THEREOF |
| 04/12/2007 | WO2007014744A3 C-terminal tnf-family ligand (ctl) -prodrug |
| 04/12/2007 | WO2007011843A3 Prevention and treatment of ophthalmic complications of diabetes |
| 04/12/2007 | WO2007010080A3 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 04/12/2007 | WO2006131515A3 Stabilised il-21 compositions |
| 04/12/2007 | WO2006124205A3 Hydrophilic polymers with pendant functional groups and method thereof |
| 04/12/2007 | WO2006123361A3 Microspheres containing goserelin or a pharmaceutically acceptable salt thereof |
| 04/12/2007 | WO2006122835B1 Colonic delivery of adsorbents |
| 04/12/2007 | WO2006069782A3 Lipid complexes coated with peg and their use |
| 04/12/2007 | WO2006050381A3 Antiviral composition |
| 04/12/2007 | WO2006045796A3 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 04/12/2007 | US20070083139 Adhesive preparations |
| 04/12/2007 | US20070082945 Discodermolide compositions |
| 04/12/2007 | US20070082867 Novel cyclodextrin dimers and derivatives thereof, methods for preparing them and their use, in particular, for the solubilizing pharmacologically active substances |
| 04/12/2007 | US20070082863 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 04/12/2007 | US20070082855 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 04/12/2007 | US20070082849 Angiogenic peptides and uses thereof |
| 04/12/2007 | US20070082363 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 04/12/2007 | US20070082047 Solid preparation |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070082037 Transdermal preparations and method for relieving side effects in pergolide therapy |
| 04/12/2007 | US20070082030 Fiber satiety compositions |
| 04/12/2007 | US20070082029 Fiber satiety compositions |
| 04/12/2007 | US20070082028 Compositions and methods for inducing satiety and reducing caloric intake |
| 04/12/2007 | US20070082027 Compositions and methods for reducing food intake and controlling weight |
| 04/12/2007 | US20070082026 Compositions and methods for reducing food intake and controlling weight |
| 04/12/2007 | US20070082025 Methods for achieving and maintaining weight loss |
| 04/12/2007 | US20070082022 Latent reactive blood compatible agents |
| 04/12/2007 | US20070082018 Stabilized antimicrobial compositions and related methods of preparation |
| 04/12/2007 | US20070082010 Urogenital or anorectal transmucosal vaccine delivery system |
| 04/12/2007 | US20070082001 Novel engineered superantigen for human therapy |
| 04/12/2007 | US20070081985 Lysozyme fortified milk and milk products |
| 04/12/2007 | US20070081971 Non-glycosylated G-CSF capable of beneficially stabilizing G-CSF without the addition of surfactants and additives derived from human and/or animal origin; long shelf life, physiologically well-tolerated, simple to use and it is possible to dose it precisely |
| 04/12/2007 | US20070081960 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity |
| 04/12/2007 | US20070081946 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 04/12/2007 | CA2854550A1 Av.beta.6 peptide ligands and their uses |
| 04/12/2007 | CA2624667A1 Silk proteins containing coiled coil region |
| 04/12/2007 | CA2624662A1 Methods and compositions for modulating immune tolerance |
| 04/12/2007 | CA2624131A1 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 04/12/2007 | CA2624111A1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/12/2007 | CA2624088A1 Sustained release small molecule drug formulation |
| 04/12/2007 | CA2624050A1 Pharmaceutical compositions stabilized in glassy particles |
| 04/12/2007 | CA2623848A1 Topical anesthetic for dental procedures |
| 04/12/2007 | CA2623031A1 Antifungal composition |
| 04/12/2007 | CA2622609A1 The use of an erythropoietin moiety to treat neurodegenerative disorders |
| 04/12/2007 | CA2621960A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 04/12/2007 | CA2609953A1 Saccharide foamable compositions |
| 04/12/2007 | CA2575827A1 Antiepileptogenic complex of albumin with docosahexaenoate |
| 04/11/2007 | EP1772156A1 Liposome-containing x-ray radiopaque dye and process for producing the same |
| 04/11/2007 | EP1771498A1 Branched polyaminoacids, functionalized by hydrophobic groups and uses thereof in particular in therapy |
| 04/11/2007 | EP1771206A2 Lipids, lipid complexes and use thereof |
| 04/11/2007 | EP1771199A1 Long-acting colloidal insulin formulation and preparation thereof |
| 04/11/2007 | EP1771198A2 Interferon-alpha polypeptides and conjugates |
| 04/11/2007 | EP1771180A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 04/11/2007 | EP1771165A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 04/11/2007 | EP1771153A1 Composition for delivery of an active agent |
| 04/11/2007 | EP1474159B1 Compositions containing oat straw and willowherb extract |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1342462B1 O/w emulsion composition and method of preparing the same |
| 04/11/2007 | EP1300143B1 Patch containing 4-biphenylacetic acid |
| 04/11/2007 | EP1272177B1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 04/11/2007 | EP1263416B1 Compressed microparticles for dry injection |
| 04/11/2007 | EP1239884B1 Methods for preparing pharmaceutical formulations |